GlassScriptPhysician profile
Vijay K Kotha
NPI 1700854395
$1,943.98
in general payments reported to CMS, 2019-2025
30 companies · $874 in 2025
The $874 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $156 · 2020: $73.63 · 2021: $92.33 · 2022: $247 · 2023: $185 · 2024: $316 · 2025: $874.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,375.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $420.79 | 2024-2025 | Keytruda, Welireg, Keytruda Qlex |
| Astellas Pharma US INC | $288.30 | 2019-2024 | Xtandi, Myrbetriq |
| Biotissue Holdings INC. | $255.08 | 2025 | |
| Boston Scientific Corporation | $100.46 | 2019-2023 | Rezum Generator |
| Sumitomo Pharma America, INC. | $87.91 | 2023-2025 | Orgovyx, Gemtesa |
| Urogen Pharma, INC. | $86.32 | 2023-2025 | Jelmyto |
| Olympus America INC. | $72.57 | 2023-2025 | Itind System |
| Medtronic, INC. | $59.58 | 2022-2024 | Interstim, Signia |
| Endo USA, INC. | $55.55 | 2024-2025 | Xiaflex |
| Procept Biorobotics Corporation | $53.43 | 2022-2024 | Aquabeam System |
| Coloplast Corp | $43.78 | 2021-2025 | |
| Progenics Pharmaceuticals, INC. | $41.95 | 2024-2025 | |
| Janssen Biotech, INC. | $37.42 | 2019-2022 | |
| Pfizer INC. | $36.95 | 2022-2025 | |
| Dendreon Pharmaceuticals LLC | $31.86 | 2024 | Provenge |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avyxa Pharma, LLC | $29.71 | 2025 | |
| Novartis Pharmaceuticals Corporation | $27.99 | 2025 | |
| Tolmar Pharmaceuticals, INC. | $20.87 | 2022 | |
| Urovant Sciences INC | $19.91 | 2022 | |
| Antares Pharma, INC. | $19.26 | 2022 | |
| Calyxo, INC. | $18.54 | 2025 | Cvac Aspiration System |
| Convatec INC. | $18.11 | 2021 | |
| Tolmar, INC. | $17.91 | 2025 | Jatenzo, Eligard |
| Baxter Healthcare | $16.25 | 2019 | |
| Photocure INC | $15.28 | 2023 | Cysview |
| Endo Pharmaceuticals INC. | $15.11 | 2019 | |
| Rochester Medical Corporation | $14.05 | 2020 | |
| Abbvie INC. | $13.70 | 2022 | |
| Srs Medical Systems, INC. | $12.91 | 2023 | Urocuff |
| Allergan, INC. | $12.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vijay Kotha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.